Daniel M. Miller

• Represented Aptose Biosciences Inc. in connection with multiple equity offerings for total proceeds of more than $200 million.
• Represented First Majestic Silver Corp. in connection with its $100 million at-the-market sale facility.
• Represented SSR Mining Inc. in connection with the $230 million debt offering.
• Represented Tekmira Pharmaceuticals Corporation (now Arbutus Biopharma Corporation) in its $150 equity offering.
• Represented Trillium Therapeutics Inc. in its $50 million initial public offering of common shares in the United States.
• Represented PetroBakken Energy Ltd. in its $900 million debt offering.
• Represented YM Biosciences Inc. on multiple equity offerings.
• Represented Petro-Canada on its $2.5 billion secondary offering of common shares by the Government of Canada (at the time, the largest ever equity offering by a Canadian company).
• Represented Pembina Pipeline Corporation in connection with filing of Cdn$3 billion shelf registration statement.

Mergers and Acquisitions  

• Represented Tekmira Pharmaceuticals Corporation (now Arbutus Biopharma Corporation) in its $750 million merger with OnCore Biopharma, Inc.
• Represented Equal Energy Ltd. in its $230 merger with Petroflow Energy Corporation.
• Represented AnorMed Inc. on its $580 million acquisition by Genzyme Corporation (which began as the first ever hostile takeover in the biotech sector).
• Represented Penn West Energy Trust on its $15 billion merger with Canetic Resources Trust.
• Represented First Majestic Silver Corp. on its $320 million acquisition of Primero Mining.
• Represented Savanna Energy Services Corp. in connection with its hostile takeover defense and $200 million acquisition by Total Energy Services Inc.
• Represented Xtreme Drilling Corp. in its $125 million merger with AKITA Drilling Ltd.